Brand-name pens allow up to 21 days at room temperature
In a series of acute studies using euglycemic clamps, Kim and colleagues demonstrated that a glucagon agonist IUB288 leads to improved glucose tolerance by augmenting insulin action with evidence of increased hepatic AKT phosphorylation (88)
SEMA, as a treatment for obesity, has shown nephroprotective effects, with a 22% reduction in the composite renal endpoint in the SELECT33 trial in patients without diabetes, supporting the role of SEMA in the management of the cardio-renal-metabolic syndrome
Sourcing and Research Considerations For either compound, the variables that most affect reproducibility are the same: identity, purity, and handling
Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
Includes a free optional microneedling accessory